Alexandria Venture Investments portfolio
72 tracked investments, 14 on the map, $3B raised across the mapped portfolio.
- Eikon Therapeutics
- insitroSeries C
- Neurona TherapeuticsSeries F
- Stoke TherapeuticsSeries B
- Ring Therapeutics
- Proxima
- HAYA TherapeuticsSeries A
- Nitrase TherapeuticsSeries A
- Xilis
- AltPepSeries B
- AitiaSeries D
- ImmunaiSeries B
- Affini-T TherapeuticsVenture
- Lycia TherapeuticsSeries C
Also in the portfolio
- NILO Therapeutics
- Sidewinder Therapeutics
- Latigo Biotherapeutics
- Seismic Therapeutic
- Avalo
- MOMA Therapeutics
- CIBO
- Affinia Therapeutics
- Nuvig Therapeutics
- Solu Therapeutics
- Dren Bio
- Enlaza Therapeutics
- ARTBIO
- Boundless Bio
- Outpace Bio
- Cajal Neuroscience
- AIRNA
- Chroma Medicine
- Ten63 Therapeutics
- Kytopen
- Leal Therapeutics
- Tr1x
- TRex Bio
- Arrakis Therapeutics
- Stratus Therapeutics
- Pleno
- Soli Organic
- Thryv Therapeutics
- Gencove
- Valora Therapeutics
- DEM BioPharma
- Halio
- Archon Biosciences
- Paratus Sciences
- Mnemo Therapeutics
- Advanced Animal Diagnostics
- Cibus
- Passkey
- Elo Life Systems
- ORIG3N
- Vesigen Therapeutics
- TwinStrand Biosciences
- Red Arrow Therapeutics
- Remedy Plan Therapeutics
- Harpe Bio
- Verseau Therapeutics
- Invaio Sciences
- Ability biologics
- Melonfrost
- Fountain Therapeutics
- miRecule
- Karuna Therapeutics
- Tavros Therapeutics
- Crop Enhancement
- Evelo Biosciences
- Imara
- Arsanis